======= PPP6R1 ======= == Gene Information == * **Official Symbol**: PPP6R1 * **Official Name**: protein phosphatase 6 regulatory subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22870|22870]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UPN7|Q9UPN7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PPP6R1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPP6R1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/610875|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulatory subunit of protein phosphatase 6 (PP6). May function as a scaffolding PP6 subunit. Involved in the PP6- mediated dephosphorylation of NFKBIE opposing its degradation in response to TNF-alpha. {ECO:0000269|PubMed:16769727}. |SAPS| |Rho GTPase binding| |vesicle targeting, rough ER to cis-Golgi| |COPII vesicle coating| |vesicle coating| |COPII-coated vesicle budding| |vesicle targeting, to, from or within Golgi| |Golgi vesicle budding| |protein phosphatase binding| |vesicle targeting| |vesicle budding from membrane| |regulation of phosphoprotein phosphatase activity| |regulation of protein dephosphorylation| |establishment of vesicle localization| |regulation of phosphatase activity| |vesicle localization| |regulation of dephosphorylation| |endoplasmic reticulum to Golgi vesicle-mediated transport| |vesicle organization| |establishment of organelle localization| |Golgi vesicle transport| |organelle localization| |Golgi membrane| |membrane organization| |regulation of hydrolase activity| |intracellular transport| |protein-containing complex assembly| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |establishment of localization in cell| |regulation of protein modification process| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.1| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.96| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-1.9| |[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.9| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.75| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|-1.7| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|1.7| |[[:results:exp285|GW501516 25μM R06 exp285]]|2.15| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.19| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.599| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9192 * **Expression level (log2 read counts)**: 7.87 {{:chemogenomics:nalm6 dist.png?nolink |}}